INNOVENT BIOLOGICS INC revenue breakdown overview

INNOVENT BIOLOGICS INC revenue for the last year amounted to 10.03 B HKD, the most of which — 10.22 B HKD — came from its highest performing source at the moment, Antibody and Protein Medicine, Pharmaceutical Products and Consultation and Research and Development Services, the year earlier bringing 6.86 B HKD. The greatest contribution to the revenue figure was made by China — last year it brought INNOVENT BIOLOGICS INC 9.74 B HKD, and the year before that — 6.36 B HKD.